血必净注射液协同治疗慢性阻塞性肺病急性加重期疗效观察

Observation Curative Effect of Xuebijing Injection Synergistic in Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease

目的观察血必净注射液对慢性阻塞性肺病急性加重期的临床治疗作用。方法将慢性阻塞性肺病急性加重期92例患者随机分为两组,各46例。对照组给予抗生素、常规止咳、化痰、平喘治疗。治疗组在对照组治疗基础上,加用血必净注射液。观察两组临床疗效和超敏C反应蛋白(hs-CRP)含量变化。结果治疗组总有效率87.6%,高于对照组69.8%,P<0.05,差异具有统计学意义;治疗前,两组hs-CRP含量比较,P>0.05,差异不具有统计学意义。治疗后,两组hs-CRP含量均下降,治疗组hs-CRP含量低于对照组,P<0.05,差异具有统计学意义。结论在常规治疗基础上,联合血必净注射液治疗慢性阻塞性肺病急性加重期,对提高临床疗效具有显著作用。

Objective To observe the clinical therapeutic effect of xuebijing injection foracute exacerbation of chronic obstructive pulmonary disease. Methods Selected 92 patients with acute exacerbation of chronic obstructive pulmonary disease, were randomly divided into two groups, each group had 46 cases. The control group given antibiotics, regular relieving cough and reducing sputum to relieve asthma treatment. the treatment group basis on the control group added xuebijing injection to treatment. To observe two groups of clinical curative effect and content change of hypersensitive C-reactive protein（hs-CRP）.Results The efficacy rate of treatment group was 87.6%, it was higher than the control group which was 69.8%,P〈0.05, was difference had statistically significance, To compared the hs-CRP content of both groups before the treatment,P〉0.05, was no difference had statistically significance. The hs-CRP content of two groups were both falling after the treatment, the treatment group was lower than the control group,P〈0.05, was difference had statistically significance.Conclusion The conventional therapy of xuebijing injection for AECOPD can improve the clinical curative effect.